-+ 0.00%
-+ 0.00%
-+ 0.00%

Mesoblast Advances Phase 3 Trial of Rexlemestrocel-L for Chronic Low Back Pain Following FDA Support

路透·01/19/2026 00:01:40

登錄查看新聞詳情